The Biotech Growth Trust PLC (BIOG.L) LSE

Currency In GBp

AD

Valuation

Market Cap294.1M
Enterprise Value306.42M
P/E Ratio3.1
PEG Ratio0
Price/Sales Ratio2.45
Price/Book Ratio1.31
Enterprise/Revenue2.54
Enterprise/EBITDA2.61

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.96
Operating Margin0.98
AD

Management Effectiveness

Return On Assets0.43
Return On Equity0.48

Income Statement

Revenue137.16M
Revenue/Share6.33
Gross Profit132.52M
EBITDA131.43M
Net Income130.26M
Diluted EPS5.58

Balance Sheet

Total Cash0
Total Cash/Share0
Total Debt12.32M
Total Debt/Equity0.04
Current Ratio0.89
Book Value Per Share13.22

Price History

52-Week Change94.61
52-Week High1,784
52-Week Low866
Moving Average 50 Days1,581.16
Moving Average 200 Days1,337.92

Statistics

Average Volume58,750
Shares Outstanding19.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD